Click Holdings Limited (NASDAQ:CLIK) Sees Significant Decrease in Short Interest

Click Holdings Limited (NASDAQ:CLIK) was the target of a significant decrease in short interest during the month of March. As of March 13th, there was short interest totaling 451 shares, a decrease of 73.5% from the February 26th total of 1,704 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 196,080 shares, the days-to-cover ratio is presently 0.0 days.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (d)” rating on shares of Click in a report on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has a consensus rating of “Sell”.

Click Trading Up 3.4%

NASDAQ:CLIK traded up $0.06 on Friday, hitting $1.84. The stock had a trading volume of 13,760 shares, compared to its average volume of 120,933. Click has a 1 year low of $1.50 and a 1 year high of $96.00. The firm’s fifty day simple moving average is $3.64 and its two-hundred day simple moving average is $5.89.

Click Company Profile

Click Therapeutics, Inc (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review.